Tabalumab, also as atacicept, represents a distinct therapeutic strategy for managing inflammatory conditions. This humanized monoclonal immunoglobulin primarily inhibits B cell inducing factor- BAFF, a crucial protein https://www.targetmol.com/compound/tabalumab